AcouSort
19,25 SEK +2,94%Vær den første som følger denne virksomhed
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ACOU
Daglig lav / høj pris
18,6 / 19,5
SEK
Markedsværdi
287,48 mio. SEK
Aktieomsætning
625,1 t SEK
Volumen
33 t
Finanskalender
Delårsrapport
28.08.2024
Delårsrapport
27.11.2024
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 10,7 % | 10,7 % |
Thomas Laurell | 7,4 % | 7,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
AcouSort and GenSensor collaboration develops according to plan
AcouSort to participate in a pioneering project to release the potential in extracellular vesicles research
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools